[144] EverQuote, Inc. SEC Filing
Rhea-AI Filing Summary
EverQuote, Inc. Form 144 shows a proposed sale of 67,364 Class A common shares through Morgan Stanley Smith Barney, with an aggregate market value of $1,581,681.02 and approximately 32,908,579 shares outstanding. The approximate sale date is 09/05/2025. The filing lists acquisition sources for the securities, primarily restricted stock vesting, performance stock units, and option exercises occurring on dates between 02/25/2025 and 09/05/2025. The filer previously sold a total of 6,488 shares in the past three months for gross proceeds of $158,358.68. The notice includes the required representation that the seller is not aware of undisclosed material adverse information.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine insider sale notice disclosing ~67k shares for ~$1.58M; transaction stems from compensation vesting and option exercises.
The filing is a standard Rule 144 notice indicating an insider intends to sell recently acquired shares arising from restricted stock vesting, performance stock units, and option exercises. Sale execution is routed through a major broker, which supports orderly disposition. Prior sales listed total 6,488 shares for roughly $158k over the past three months, indicating ongoing, aggregated dispositions. This filing alone provides transaction detail but no new operating or financial performance data.
TL;DR: Disclosure aligns with compliance expectations; filings show multiple compensation-related acquisitions and subsequent planned sales.
The notice meets disclosure obligations under Rule 144 by identifying the broker, security class, number of shares, aggregate value, and the acquisition history tied to compensation and option exercises. The signer affirms absence of undisclosed material information. Multiple vesting dates and large option exercises on or near the sale date are documented, which is important for audit trails and insider-trading compliance reviews.